Web9 de dez. de 2024 · About Highland Therapeutics Inc. Through its wholly owned subsidiary, Ironshore Pharmaceuticals & Development, Inc., Highland developed JORNAY PM, the first and only stimulant medication that... Web1 de set. de 2016 · The ADHD market has been dominated by stimulant therapy, with only three approved non-stimulant drugs approved that cannot compete with stimulant drugs in terms of efficacy. Due to lack of evidence for long-term safe use of stimulants, non-stimulants are becoming increasingly popular in the 7MM.
Highland Therapeutics Announces Appointment of Stephanie …
Web28 de set. de 2024 · Highland Therapeutics was developing a proprietary modified-release formulations of amfetamine: HLD 100, for the treatment of attention-deficit hyperactivity … Web15 de ago. de 2013 · Highland Therapeutics Inc. is a client of MaRS Discovery District's Life Sciences and Healthcare practice, which provides advisory services and support to help Ontario life sciences companies grow ... biron bridge manchester nh
Highland Therapeutics Announces the Issuance of Two U.S.
Web6 de out. de 2014 · Highland Therapeutics Inc. is a client of MaRS Discovery District's Health Venture Services group, which provides advisory services, connections to talent, customer & capital networks, and market ... Web24 de jan. de 2024 · Highland Therapeutics, the parent company of Ironshore Pharmaceuticals, has secured a $263 million private placement due by 2024.Morgan Stanley acted as sole placement agent for the transaction. Based at MaRS in Toronto, Highland plans to use the funding to commercialize and market its signature product, … Web5 de mai. de 2024 · Highland Therapeutics / Ironshore Pharmaceuticals May 2008 - Present15 years Toronto / Cayman Islands Sr. Vice President Broadpoint Capital … dangote foundation ceo